HORMONE-REFRACTORY PROSTATE CANCER
Clinical trials for HORMONE-REFRACTORY PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new HORMONE-REFRACTORY PROSTATE CANCER trials appear
Sign up with your email to follow new studies for HORMONE-REFRACTORY PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Genetic test could match men to more effective cancer drug
Disease control OngoingThis study is testing if a genetic test can identify men with advanced prostate cancer who might benefit most from a specific chemotherapy drug called carboplatin. It involves men whose cancer has spread and stopped responding to standard hormone therapies. The goal is to see if …
Matched conditions: HORMONE-REFRACTORY PROSTATE CANCER
Phase: PHASE2 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists scan brains to see if cancer drugs cause 'Chemo Brain'
Knowledge-focused OngoingThis study aims to understand if two common prostate cancer drugs, abiraterone and enzalutamide, affect memory, concentration, and other thinking skills. Researchers will use brain scans and cognitive tests to compare 100 men with advanced prostate cancer who are taking these dru…
Matched conditions: HORMONE-REFRACTORY PROSTATE CANCER
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC